Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists-Reference-Cited by-同舟云学术

Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists

Published:2011-10 Issue:1-2 Volume:373 Page:229-239
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Lallemand Christophe,Kavrochorianou Nadia,Steenholdt Casper,Bendtzen Klaus,Ainsworth Mark A.,Meritet Jean-Francois,Blanchard Brigitte,Lebon Pierre,Taylor Peter,Charles Peter,Alzabin Saba,Tovey Michael G.

Funder

CNRS

Aase and Ejnar Danielsen's Foundation

Beckett Foundation

Danish Colitis–Crohn Society

Danish Medical Association Research Foundation

Frode V. Nyegaard and wife's Foundation

Health Science Research Foundation of Region of Copenhagen

Herlev Hospital Research Council

Lundbeck Foundation

P. Carl Petersens Foundation

Danish Biotechnology Program

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Menstrual and hormonal alterations in juvenile dermatomyositis;Aikawa;Clin. Exp. Rheumatol.,2010

2. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease;Baert;N. Engl. J. Med.,2003

3. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab;Bendtzen;Arthritis Rheum.,2006

4. Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies;Bendtzen;Scand. J. Gastroenterol.,2009

5. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells;Bersani;Immunology,1986

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels;Heliyon;2023-11

2. Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab;The Journal of Applied Laboratory Medicine;2023-09-02

3. Formulation and characterization of insulin nanoclusters for a controlled release;International Journal of Biological Macromolecules;2023-04

4. Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge;Biosensors and Bioelectronics;2022-06

5. Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study;Rheumatology and Therapy;2022-05-20